ZNTL
Zentalis Pharmaceuticals, Inc.
$4.06-0.19 (-4.47%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
Insider Activity
7 of 20 tradesExecutives investing their own money
🤖 AI InsightHaiku 4.5
Zentalis Pharmaceuticals, Inc. (ZNTL) is a publicly traded company with 7 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 3 unique insiders. All recorded transactions were sales totaling $127K. Note that insider selling can occur for many reasons (diversification, tax planning, pre-scheduled 10b5-1 plans) and is not always a bearish signal. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 20 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-10 | 2026-02-09 | Bruns Ingmar | CMO | Sale | 335 | $2.39 | $802 | N/A | N/A |
| 2026-02-10 | 2026-02-06 | Bruns Ingmar | CMO | Sale | 2,962 | $2.43 | $7,198 | N/A | N/A |
| 2026-02-10 | 2026-02-10 | Vultaggio Vincent | PAO And PFO | Sale | 6,894 | $2.42 | $16,697 | N/A | N/A |
| 2026-02-10 | 2026-02-09 | Vultaggio Vincent | PAO And PFO | Sale | 3,379 | $2.39 | $8,086 | N/A | N/A |
| 2026-02-10 | 2026-02-06 | Vultaggio Vincent | PAO And PFO | Sale | 29,951 | $2.43 | $72,781 | N/A | N/A |
| 2026-02-10 | 2026-02-09 | Eastland Julia Marie | CEO | Sale | 889 | $2.39 | $2,127 | N/A | N/A |
| 2026-02-10 | 2026-02-06 | Eastland Julia Marie | CEO | Sale | 7,866 | $2.43 | $19,114 | N/A | N/A |
| 2026-01-09 | 2026-01-08 | Eastland Julia Marie | CEO | Award | 775,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-08 | Bruns Ingmar | CMO | Award | 365,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-08 | Bucher James B | CLO | Award | 100,000 | $0.00 | $0 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.